|
Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 10, No. 4, 2000, pp. 13-15
|
Bioline Code: au00039
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
|
Australasian Biotechnology (backfiles), Vol. 10, No. 4, 2000, pp. 13-15
| en |
BIOTECH BUSINESS
Abstract
Bresagen Anti-Cancer Drug Completes Phase 1 Trial
Bresagen Gets Further U.S. Funding For Pig Cloning
Bionomics to Make $5 Million Placement
NEW FLOATS
Analytica Ltd
Sirtex Medical Ltd
GroPep Ltd
Q-VIS FLOATS
Pi2 LISTING
Progen DEVELOPMENT
Virax and IDT win $27 million contract
Applied Biosystems
Axon Instruments and CSIRO Announce Collaboration
Axon Instruments announces profit INCREASE
Meditech Research to Conduct Human Trials
ANADIS BLOOD TECHNOLOGY TRIALLED
NORWOOD ABBEY FLOAT
BIOENTERPRISES TO MAKE MELANOMA VACCINE
CHEMEQ ULCER TREATMENT PROGRESSES
AMRAD HANDS OVER ICT BUSINESS
CROWN SCIENTIFIC TO DISTRIBUTE GENELINE
|
| |
© Copyright 2000 - Australasian Biotechnology
Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16
|
|
